Work

Supplemental Figure 1 from MHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment In Vitro

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Figure 1. Immunohistochemical staining for tumor-infiltrating leukocyte populations in papillary thyroid cancer specimens and control tissues. Examples of positive and negative staining are shown (original magnification 400x), with black arrows demonstrating instances of positively stained target cells for each stain.

DOI: 10.1158/1078-0432.22454523.v1

Authors: Trevor E. Angell, Melissa G. Lechner, Julie K. Jang, Jonathan S. LoPresti, Alan L. Epstein

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361909634

Cites:

Cited by:

Related to: 10